Cargando…

Dupilumab Use Is Associated With Protection From Coronavirus Disease 2019 Mortality: A Retrospective Analysis

We previously found that type 2 immunity promotes coronavirus disease 2019 (COVID-19) pathogenesis in a mouse model. To test relevance to human disease, we used electronic health record databases and determined that patients on dupilumab (anti-interleukin [IL]-4R monoclonal antibody that blocks IL-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donlan, Alexandra N, Mallawaarachchi, Indika, Sasson, Jennifer M, Preissner, Robert, Loomba, Johanna J, Petri, William A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494491/ https://www.ncbi.nlm.nih.gov/pubmed/36104868 http://dx.doi.org/10.1093/cid/ciac745

Ejemplares similares

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial
por: Sasson, Jennifer, et al.
Publicado: (2022)

Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial
por: Sasson, Jennifer, et al.
Publicado: (2022)

Minimal Population Prevalence and Mortality of Coronavirus Disease 2019 in Healthcare Personnel
por: Gupta, Kalpana, et al.
Publicado: (2020)

Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
por: Tanabe, Naoya, et al.
Publicado: (2021)

Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023)

Adherence to Lung Protective Ventilation in Patients With Coronavirus Disease 2019
por: Levy, Elizabeth, et al.
Publicado: (2021)

Early Adoption of Dupilumab in the Medicare Population in 2017
por: Cheraghlou, Shayan, et al.
Publicado: (2020)

The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis
por: Ungar, Benjamin, et al.
Publicado: (2022)

Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study
por: Eijmael, Marjella, et al.
Publicado: (2021)

Combination Therapy With Tocilizumab and Dexamethasone Cost-Effectively Reduces Coronavirus Disease 2019 Mortality
por: Sinha, Pranay, et al.
Publicado: (2021)

New Onset of Alcohol Flushing in an Atopic Dermatitis Patient Treated with Dupilumab
por: Choi, Hoon, et al.
Publicado: (2023)

A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab
por: Jiang, Xiaoyun, et al.
Publicado: (2023)

Point-of-Care Lung Ultrasound for Detecting Severe Presentations of Coronavirus Disease 2019 in the Emergency Department: A Retrospective Analysis
por: Favot, Mark, et al.
Publicado: (2020)

A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019
por: King, Alexander H., et al.
Publicado: (2021)

One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis
por: Lee, Hanjae, et al.
Publicado: (2021)

Increased stroke severity and mortality in patients with SARS-CoV-2 infection: An analysis from the N3C database
por: Narrett, Jackson A, et al.
Publicado: (2023)

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
por: Lee, Dong Hun, et al.
Publicado: (2022)

A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient
por: Hogan, John I, et al.
Publicado: (2021)

In-Hospital Mortality Among Hospitalized Coronavirus Disease 2019 Patients in the United States: How Did It Change in 2021?
por: Moon, Rena C, et al.
Publicado: (2022)

Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study
por: Mansoor, Emad, et al.
Publicado: (2021)

Antivirals With Adjunctive Corticosteroids Prevent Clinical Progression of Early Coronavirus 2019 Pneumonia: A Retrospective Cohort Study
por: Ooi, Say Tat, et al.
Publicado: (2020)

A teenager with CHD and coronavirus disease 2019
por: Olfe, Jakob, et al.
Publicado: (2020)

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022)

Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
por: Routsi, Christina, et al.
Publicado: (2021)

Development and Structure of an Accurate Machine Learning Algorithm to Predict Inpatient Mortality and Hospice Outcomes in the Coronavirus Disease 2019 Era
por: Chi, Stephen, et al.
Publicado: (2022)

Nonverbal Neurocognitive Assessment during the Coronavirus Disease of 2019 Pandemic: the Effect of Personal Protective Equipment
por: Lichtenstein, Jonathan, et al.
Publicado: (2022)

Clinical Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Tests for Diagnosing Coronavirus Disease 2019
por: Ridgway, Jessica P, et al.
Publicado: (2020)

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2021)

Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
por: Regan, James, et al.
Publicado: (2021)

Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City
por: Mathad, Jyoti S, et al.
Publicado: (2021)

Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18–65 years
por: Bhargava, Ashish, et al.
Publicado: (2020)

Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States
por: Loomba, Rohit S., et al.
Publicado: (2020)

Coronavirus Disease 2019: Associated Multiple Organ Damage
por: Collange, Olivier, et al.
Publicado: (2020)

Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients
por: Newman, Alexander M., et al.
Publicado: (2021)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

First Pediatric Case of Coronavirus Disease 2019 in Korea
por: Park, Ji Young, et al.
Publicado: (2020)

Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study
por: Bertlich, Mattis, et al.
Publicado: (2022)

Risk of coronavirus disease 2019 (COVID-19) acquisition among emergency department patients: A retrospective case control study
por: Ridgway, Jessica P., et al.
Publicado: (2020)

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus-2 IgG antibody response to coronavirus disease 2019 vaccination in South Indian health-care professionals with and without coronavirus disease 2019 exposure
por: Jayashri, Ramamoorthy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8euatdkjatb0ifaoicekkf6nvs